Skip to content
We’ve expanded our free plan so you can explore more of Valuesider. Check out the updated pricing page to see what’s now available for free!
Gilead Sciences Inc

Gilead Sciences Inc buys & sells (2013 Q2)

GILD

GILD Institutional Purchase & Sale

Purchase & sale details

# of activities:
3
AVG reported price*:
$51.27
Current price*:
+202.15%($154.91)
3 value investing gurus have made changes to the Gilead Sciences Inc (GILD) position according to the gurus' 2013 Q2 SEC quarterly report(s). GILD has been bought (as a new position) by 3 guru(s)

Which gurus or hedge funds bought GILD in 2013 Q2?

According to the 2013 Q2 SEC filing(s) Gilead Sciences Inc (GILD) has been bought by 3 gurus / funds: David Rolfe - Wedgewood Partners (new buy), Ole Andreas Halvorsen - Viking Global Investors (new buy) and Ronald Muhlenkamp - Muhlenkamp & Co (new buy).
To see more about who is investing in Gilead Sciences Inc (GILD), please go to the GILD ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted. 2013 Q2 is the earliest period we have data for, so "2013 Q2*" means "2013 Q2 or earlier".